METABOLIC SYNDROME: GENDER INEQUALITIES, INTERDISCIPLINARY CARE AND DECISION MAKING IN PUBLIC HEALTH
PDF

Palavras-chave

Metabolic Syndrome. Epidemiology. Decision making. Artificial intelligence. Public health.

Como Citar

Freitas Macedo, S. ., Thamalla Mendes dos Santos, S. ., Paula Santos Resende, A. ., Izabel Pezarini Jiacon, M. ., & Gomide Nolasco de Assis, J. . (2026). METABOLIC SYNDROME: GENDER INEQUALITIES, INTERDISCIPLINARY CARE AND DECISION MAKING IN PUBLIC HEALTH. Revista Gênero E Interdisciplinaridade, 7(01), 430-446. https://doi.org/10.51249/gei.v7i01.2824

Resumo

Metabolic syndrome (MS) constitutes one of the greatest challenges in global public health, characterized by a set of interrelated changes that substantially increase the risk of cardiovascular diseases, type 2 diabetes and mortality. It occurs especially in women, the elderly and individuals with low education. Such findings highlight structural inequalities that require an intersectional and interdisciplinary approach when formulating care strategies. This integrative review aimed to synthesize recent scientific evidence on the epidemiology, pathophysiological mechanisms and care and decision-making strategies related to MS. The search was carried out in June 2025 in the Scopus, PubMed, CINAHL, LILACS, SciELO, Google Scholar and Web of Science databases, using DeCS and MeSH descriptors, with a time frame from 2015 to 2025. Of the 1,238 studies initially identified, 10 met the inclusion criteria. The results showed a global prevalence of MS between 20% and 30%, with rates of 38.4% in the Brazilian adult population, especially in women, the elderly and individuals with low education. Studies have highlighted central mechanisms such as insulin resistance, chronic low-grade inflammation and endothelial dysfunction, in addition to serious clinical consequences. The need for multidisciplinary care models, cultural adaptation of clinical protocols and integration of digital technologies and artificial intelligence to optimize clinical decision-making and treatment personalization was also identified. It is concluded that tackling MS requires integrated interventions, robust public policies and investments in technological innovation, in addition to strengthening multidisciplinary care and the development of population-based preventive strategies.

PDF

Referências

AMERICAN HEART ASSOCIATION; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation, v. 112, n. 17, p. 2735–2752, 2005. DOI: 10.1161/CIRCULATIONAHA.105.169405.

BOOTH, A. et al. Searching for qualitative research for inclusion in systematic reviews: a structured methodological review. Systematic Reviews, v. 5, n. 74, p. 1–23, 2016. DOI: 10.1186/s13643-016-0249-x.

CHANG, S. et al. Research trends on metabolic syndrome in digital health care. Journal of Medical Internet Research, v. 26, e53873, 2024. DOI: 10.2196/53873.

CHEN, Y. et al. Artificial intelligence-assisted nutritional risk evaluation model for critically ill patients. Journal of Diabetes & Metabolic Disorders, 2025. DOI: 10.1007/s40200-025-01648-y.

GONZÁLEZ-OROZCO, A. et al. Adaptation of the Nutrition Care Process for metabolic diseases in the Mexican population. Frontiers in Nutrition, v. 12, 1513747, 2025. DOI: 10.3389/fnut.2025.1513747.

HUANG, W. et al. Prediction of malnutrition risk in hospitalized patients using machine learning and routine laboratory data. Asia Pacific Journal of Clinical Nutrition, v. 34, n. 3, p. 343–352, 2025. Disponível em: https://apjcn.nhri.org.tw/server/APJCN/34/3/343.pdf.

INTERNATIONAL DIABETES FEDERATION. IDF consensus worldwide definition of the metabolic syndrome. Brussels: IDF, 2006. Disponível em: https://idf.org/media/uploads/2023/05/attachments-31.pdf.

LEE, H. et al. Changes of metabolic syndrome status alter the risks of cardiovascular diseases, stroke, and all-cause mortality. Scientific Reports, v. 15, 86385, 2025. DOI: 10.1038/s41598-025-86385-1.

MALTA, D. C. et al. Prevalência da síndrome metabólica e seus componentes na população adulta brasileira. Ciência & Saúde Coletiva, v. 25, n. 11, p. 4201–4212, 2020. DOI: 10.1590/1413-812320202511.31202020.

MUKHERJEE, D.; BHATTACHARYYA, P. Metabolic syndrome: from mechanisms to interventions. Amsterdam: Elsevier, 2023.

NADZIEJEWSKA, M. et al. Epidemiology of metabolic syndrome. Pflügers Archiv - European Journal of Physiology, v. 477, p. 123–136, 2025. DOI: 10.1007/s00424-024-03051-7.

ORSINI, N. et al. Epidemiological impact of metabolic syndrome in overweight and obese European children and adolescents. Nutrients, v. 15, n. 18, 3895, 2023. DOI: 10.3390/nu15183895.

ORGANIZAÇÃO MUNDIAL DA SAÚDE. Noncommunicable diseases. Geneva: WHO, 2023. Disponível em: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases.

SOCIEDADE BRASILEIRA DE CARDIOLOGIA. Diretrizes da Sociedade Brasileira de Cardiologia sobre o tratamento da obesidade. Arquivos Brasileiros de Cardiologia, 2022. Disponível em: https://www.scielo.br/j/abc/a/qWzJH647dkF7H5dML8x8Nym.

SOUZA, R.; PEREIRA, F. Síndrome metabólica: compreendendo e combatendo uma epidemia moderna. Brazilian Journal of Health Review, v. 6, n. 1, p. 789–804, 2023.

STATPEARLS PUBLISHING. Metabolic syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2025. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK459248/.

TORONTO, C. E.; REMINGTON, R. A simple guide for completing an integrative review using an example article. Journal of Professional Nursing, v. 40, p. 13–19, 2022. DOI: 10.1016/j.profnurs.2022.02.004.

WANG, Y. et al. Machine learning-based models for clinical nutrition risk assessment. Journal of Diabetes & Metabolic Disorders, 2025. DOI: 10.1007/s40200-025-01648-y.

YANG, L. et al. Developmental trends of metabolic syndrome in the past two decades. Journal of Clinical Medicine, v. 14, n. 7, 2402, 2025. DOI: 10.3390/jcm14072402.